Nuplazid (Pimavanserin) for Parkinson's disease

Overview
Nuplazid is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease. Nuplazid is also known by its drug name, pimavanserin.

Nuplazid is an atypical antipsychotic. Antipsychotics are drugs used to manage psychiatric problems such as delusions and disordered thoughts. Nuplazid is believed to work by interfering with serotonin receptors in the brain.

How do I take it?
Nuplazid is taken once a day.

Nuplazid is available in tablet form.

Side effects
The FDA-approved label for Nuplazid lists common side effects including confused state and peripheral edema (swelling of the legs, feet, or ankles).

Rare but serious side effects listed for Nuplazid can include heart rhythm changes.

For more details about this treatment, visit:

Nuplazid — Acadia
www.nuplazid.com